{"id":"W1522676959","doi":"10.1111/bcp.12662","title":"Pharmacokinetics and safety of subcutaneous rituximab plus fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemia","year":2015,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"F. Hoffmann-La Roche","keywords":"Rituximab; Medicine; Fludarabine; Cyclophosphamide; Pharmacokinetics; Internal medicine; Urology; Pharmacology; Gastroenterology; Chemotherapy; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00163798,0.000222339,0.001476533,0.0001176788,0.00006422444,0.00002241665,0.0002064938,0.0002271755,0.0000765547],"category_scores_gemma":[0.001250925,0.0002030265,0.0001718085,0.0001694285,0.0009293724,0.0001326707,0.0001433563,0.0006295891,0.000002486289],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.005055271,"about_ca_system_score_gemma":0.01584388,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001091315,"about_ca_topic_score_gemma":0.00001833024,"domain_scores_codex":[0.9965209,0.0002302282,0.00178852,0.000352189,0.0006166507,0.0004915173],"domain_scores_gemma":[0.995225,0.001567167,0.000793063,0.0001370448,0.00138436,0.0008933436],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.327877,0.005625697,0.04678754,0.00482206,0.005677404,0.02435612,0.0004682351,0.002984737,0.001576383,0.00006786302,0.09168472,0.4880722],"study_design_scores_gemma":[0.8292654,0.02982349,0.02210739,0.001238554,0.002835851,0.05006898,0.00006712227,0.02661388,0.001482723,0.0002750639,0.03562845,0.0005930899],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9871656,0.01028683,0.0002425143,0.0002837597,0.0008720238,0.0009442478,0.00005764898,0.00001309814,0.0001343066],"genre_scores_gemma":[0.986251,0.01000999,0.001936549,0.0005898429,0.0009908217,0.0000113863,0.00001573729,0.00005054682,0.0001441232],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5013884,"threshold_uncertainty_score":0.9987642,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03402879915857482,"score_gpt":0.3734540108024317,"score_spread":0.3394252116438569,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}